GET RESOURCE
Please provide the requested details below to download the document.
ACCEPTABILITY OF IMPLANTABLE CGM (EUROPE) – 2017

This European study included 51 participants with Type 1 and Type 2 diabetes. It showed that the Eversense CGM with under-the-skin sensor was widely accepted by users and favorably evaluated by a high percentage of participants in the study.